XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Stock-based Compensation Expense

Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company’s stock-based awards, was as follows:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Cost of revenue

 

$

130

 

 

$

146

 

 

$

467

 

 

$

268

 

Selling and marketing

 

 

564

 

 

 

581

 

 

 

1,464

 

 

 

1,518

 

Research and development

 

 

326

 

 

 

395

 

 

 

1,006

 

 

 

1,068

 

General and administrative

 

 

605

 

 

 

1,086

 

 

 

5,617

 

 

 

2,921

 

Total stock-based compensation

 

$

1,625

 

 

$

2,208

 

 

$

8,554

 

 

$

5,775

 

Stock Activity and Total Number of Shares Available for Grant

The following table presents the stock activity and the total number of shares available for grant as of September 30, 2023:

 

 

 

(in thousands)

 

Balance at December 31, 2022

 

 

550

 

Plan Amendment

 

 

1,049

 

Options Cancelled

 

 

20

 

Restricted Stock Granted

 

 

(504

)

Restricted Stock Forfeited

 

 

21

 

Performance Shares Unearned

 

 

94

 

Performance Shares Granted

 

 

(163

)

Balance at September 30, 2023

 

 

1,067

 

Stock Option Activity

 

 

Options Outstanding

 

 

 

Number of
Shares
Underlying
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Outstanding at December 31, 2022

 

 

1,577,545

 

 

$

7.66

 

 

 

5.81

 

 

$

2,465,015

 

Options Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Options Exercised

 

 

(419,233

)

 

 

4.10

 

 

 

 

 

 

 

Options Forfeited

 

 

(19,676

)

 

 

15.78

 

 

 

 

 

 

 

Outstanding at September 30, 2023

 

 

1,138,636

 

 

$

8.83

 

 

 

4.37

 

 

$

2,363,338

 

Vested and expected to vest at September 30, 2023

 

 

1,138,899

 

 

$

8.94

 

 

 

4.36

 

 

$

2,361,278

 

Exercisable at September 30, 2023

 

 

1,043,268

 

 

$

8.97

 

 

 

4.16

 

 

$

2,182,154

 

Restricted Stock Awards  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Restricted Stock Activity

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Nonvested restricted stock at December 31, 2022

 

 

865,446

 

 

$

18.75

 

Granted

 

 

504,092

 

 

 

9.97

 

Vested

 

 

(565,581

)

 

 

16.44

 

Shares forfeited

 

 

(21,208

)

 

 

17.64

 

Nonvested restricted stock at September 30, 2023

 

 

782,749

 

 

$

14.80